Implantable Pumps Require Specific Medications To Prevent Pump Failure And Risks To Patient SafetyAschenbrenner, Diane S., MS, RNAJN The American Journal of Nursing: April 2019 - Volume 119 - Issue 4 - p 20–21 doi: 10.1097/01.NAJ.0000554545.18267.9d Drug Watch Buy Abstract Author InformationAuthors Article MetricsMetrics The Food and Drug Administration has issued a Safety Communication regarding implantable pumps used for drug administration and the risks of using medications not approved for use with the pumps to treat or manage pain. Nurses who work with patients receiving intrathecal delivery of pain medication via an implantable pump are urged to carefully read the pump's labeling to identify which medications are approved for use with the pump. Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: firstname.lastname@example.org. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.